The Potential Role of Growth Hormone on the Endometrium in Assisted Reproductive Technology
Overview
Authors
Affiliations
Growth hormone (GH) has been considered as an adjuvant treatment in human assisted reproductive technology (ART) for several years. Its action was largely attributed to an improvement of ovarian function and less emphasis was paid to its role in the uterus. However, there is increasing evidence that GH and its receptors are expressed and have actions in the endometrium and may play an important role in modifying endometrial receptivity. Thus, in this review, we firstly describe the existence of GH receptors in endometrium and then summarize the effects of GH on the endometrium in clinical situations and the underlying mechanisms of GH in the regulation of endometrial receptivity. Finally, we briefly review the potential risks of GH in ART and consider rationalized use of GH treatment in ART.
Ran L, Wang X, Ma R, Wang H, Wu Y, Yu Z Biol Sex Differ. 2024; 15(1):98.
PMID: 39623508 PMC: 11610217. DOI: 10.1186/s13293-024-00676-2.
Atosiban interacts with growth hormones as adjuvants in frozen-thawed embryo transfer cycles.
Chen H, Cai J, Sun X, Liu L, Liu Z, Gao P Front Endocrinol (Lausanne). 2024; 15:1380778.
PMID: 38841302 PMC: 11150816. DOI: 10.3389/fendo.2024.1380778.
Mohammadshirazi Z, Alyasin A, Agha Hosseini M, Hazari V J Reprod Infertil. 2024; 24(4):279-286.
PMID: 38164424 PMC: 10757689. DOI: 10.18502/jri.v24i4.14155.
Metabolic hormones are integral regulators of female reproductive health and function.
Athar F, Karmani M, Templeman N Biosci Rep. 2023; 44(1).
PMID: 38131197 PMC: 10830447. DOI: 10.1042/BSR20231916.
Effect of growth hormone cotreatment in sub-fertile women ≥ 40 years: A Meta-analysis.
Elkalyoubi M, Schindler L, Zaheer H Reprod Fertil. 2023; .
PMID: 36807147 PMC: 10083671. DOI: 10.1530/RAF-22-0107.